Follow The Filings

GMAB Genmab A/S

Genmab A/S earnings company data as of 8:02 PM ET 10/22

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 5 Nov EPS 0.35 — —
Rev — — —

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
6-K
6-K
SCHEDULE 13G —
6-K
6-K
6-K
6-K
6-K
6-K
6-K
SCHEDULE 13G/A —
6-K
6-K
6-K
6-K
6-K
6-K
6-K
6-K
6-K
6-K
6-K
SCHEDULE 13G/A —
6-K
6-K

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.